Track I:

Abbreviated Treatment (6-9 mo)

  • Treatment Readiness Meeting (1-4 Weeks)
  • Bi-Weekly Individual (During 3 Month Assessment/Orientation)
  • Monthly Individual (After 3 Month Assessment/Orientation)
  • No Groups required

Track II:

Low/Moderate Risk (12-18 mo)

  • Treatment Readiness Meeting (1-4 Weeks)
  • Weekly Group
  • Monthly Individual (During 2 Month Assessment/Orientation)
  • As Needed Individual (After 2 Month Assessment/Orientation as prescribed by Tx)

Track III:

Moderate/High Risk (18-24 mo)

  • Treatment Readiness Meeting (1-4 Weeks)
  • Weekly Group
  • Monthly Individual (During first 12 mo)
  • As Needed Individual (After first 12 mo as prescribed by Tx)